INTELLIA THERAPEUTICS, INC. (NTLA) Operating cash flow 2016–2025
INTELLIA THERAPEUTICS, INC. (NTLA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$394.7MFY2025 · since FY2016: $36.1M → -$394.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$394.7M | -13.1% |
| FY2024 | -$348.9M | +11.5% |
| FY2023 | -$394.1M | -18.2% |
| FY2022 | -$333.3M | -48.1% |
| FY2021 | -$225.0M | -350.9% |
| FY2020 | -$49.9M | +51.7% |
| FY2019 | -$103.2M | -68.5% |
| FY2018 | -$61.3M | +6.2% |
| FY2017 | -$65.3M | -280.8% |
| FY2016 | $36.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NTLA financial trends
NTLA RevenueNTLA Net incomeNTLA Net marginNTLA Gross profitNTLA Gross marginNTLA Operating incomeNTLA Operating marginNTLA Free cash flowNTLA Capital expendituresNTLA Return on equityNTLA Stock buybacksNTLA Dividends paidNTLA Total assetsNTLA Total liabilitiesNTLA Shareholders’ equityNTLA overview →